HomeBusinessHealthcare Industry Stock NewsGreenwich Lifesciences (GLSI) CEO On Latest Clinical Data

Greenwich Lifesciences (GLSI) CEO On Latest Clinical Data

The CEO of Greenwich Lifesciences (GLSI) Snehal Patel joins Nicole to discuss the company’s latest innovations, including the results of five years’ worth of clinical trial data revealing potential for new T Cell platform technology, which the company announced at the 2021 San Antonio Breast Cancer Symposium. Founded in 2006, Greenwich Lifesciences is a clinical stage biopharmaceutical company that focuses on developing cancer immunotherapy, including for breast cancer.

The Watch List

09 Dec 2021

SHARE

ON AIR
6:30 am
Trading 360
replay
12:00 am
Fast Market
REPLAY
education
1:00 am
Your First Trade
REPLAY
1:30 am
Next Gen Investing
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Trading 360
REPLAY
4:00 am
Fast Market
REPLAY
5:00 am
Next Gen Investing
REPLAY
education
6:00 am
Your First Trade
REPLAY
ON AIR
6:30 am
Trading 360
REPLAY
7:30 am
Fast Market
REPLAY
8:30 am
Next Gen Investing
REPLAY
9:30 am
Market Overtime
REPLAY
10:00 am
Trading 360
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Your First Trade
REPLAY
1:30 pm
Trading 360
REPLAY
2:30 pm
Fast Market
REPLAY
3:30 pm
Next Gen Investing
REPLAY
4:30 pm
Market Overtime
REPLAY
5:00 pm
Trading 360
REPLAY
6:00 pm
Fast Market
REPLAY
7:00 pm
Next Gen Investing
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Trading 360
REPLAY
9:30 pm
Fast Market
REPLAY
10:30 pm
Next Gen Investing
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor

coming soon

We are now

coming soon

We are now